title: Advances in paracoccidioidomycosis.
abstract: Paracoccidioidomycosis is the most prevalent systemic mycosis in Latin America. It is becoming globally relevant, as increasing numbers of cases have been detected in returning travellers and immigrants from endemic regions. It is characterized by pulmonary involvement, lymphadenopathy, and chronic progression of mucocutaneous lesions. Untreated, systemic disease can be severe and fatal. Skin features are common and characteristic, enabling the dermatologist to diagnose infection early and prevent the development of serious sequelae. This review outlines the clinical features and management of paracoccidioidomycosis and discusses notable recent developments in molecular diagnosis, prognostics and therapies.
authors.affiliation: St. John's Institute of Dermatology, Guy's and St Thomas' NHS Trust, London SE1 7EH, UK. mahreenameen@hotmail.com
authors.forename: M
authors.initials: M
authors.lastname: Ameen
authors.forename: C
authors.initials: C
authors.lastname: Talhari
authors.forename: S
authors.initials: S
authors.lastname: Talhari
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D007843:Latin America; D008297:Male; D010228:Paracoccidioides / Q000302:isolation & purification*; D010229:Paracoccidioidomycosis / Q000473:pathology / Q000628:therapy*; D055815:Young Adult